Omicron (B.1.1.529) Spike RBD Available from ProSci
Cat. No. 21-801
ProSci has launched Omicron variant spike RBD protein with 15 mutations: G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y, Y505H
The World Health Organization (WHO) has designated the Omicron variant as a Variant of concern (VOC). According to scientists in southern Africa, Omicron is now the most contagious variant with at least twice the spreading speed compared to the Delta variant. Omicron variant spike protein includes mutations, deletions, and insertions, which are related to transmissibility increase, immune escape, and resistance to monoclonal antibody treatments.
Searching for an Antibody?
ProSci Inc. offers a Comprehensive Antibody Catalog for one-stop shopping to meet all your antibody needs. Search the catalog for antibodies against your target(s) or Search using the Primary Antibodies menu, filtering for example, according to Research Area. ProSci Inc. antibodies are validated for application and protocols are available describing our procedures.
Reflecting our strong commitment to supporting biomedical research we were one of the first companies to offer Spike protein antibodies (Cat. No. 3525) for SARS-CoV-2 (COVID-19) research. Below we feature links to pages listing Antibody and Recombinant Protein products focused on COVID-19 and other significant Viral Infectious Diseases.
Viral Infectious Diseases Research ReagentsProSci offers antibodies and proteins to over 40 infectious disease targets including Coronavirus, HIV, and Influenza. |
Coronavirus Research ReagentsAntibodies and recombinant proteins for SARS, MERS, human CoV, including SARS-CoV-2 viral research. |
HIV Research ReagentsAntibodies and recombinant proteins to support global |
Influenza Virus Research ReagentsAntibodies and recombinant proteins for influenza virus targets such as H5N1, H1N1, and more! |
SARS-CoV-2 Matched Antibody PairsThese pairs include antibodies against spike s1, spike RBD, and nucleocapsid proteins. |
Antibodies Validated with Patient SamplesAntibodies against structural SARS-CoV-2 proteins validated with COVID-19 positive patient tissue samples. |
ACE2 and Related TargetsAngiotensin-converting enzyme 2, has been shown to be the receptor for SARS-CoV-2 through binding of its Spike protein. |
Cytokine StormProSci offers antibodies and recombinant proteins for many factors involved in the inflammatory response. |
5A's Antibody Guide
Inside our antibody development guide section, you will find information about how our custom antibody services work, the challenges we face, and how we resolve them.
San Diego Company
ProSci is proud to be a local San Diego antibody company devoted to R&D and committed to the design, development, and production of high-performance antibodies.
ProSci Blog
Learn more about ProSci's experience with creating antibodies for difficult antigens and new developments in antibody research through our blog posts.
